Vascular Imaging and Radiation Safety

Comprehensive Vascular and Endovascular Surgery: Second Edition

Volumn , Issue , 2009, Pages 73-116

  Guimaraes, Marcelo ^a   Schönholz, Claudio ^a   Uflacker, Renan ^a   Huda, Walter ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954749708     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05726-4.00007-X     Document Type: Chapter

References (127)

1. Rutkow I.M., Ernst C.B. An analysis of vascular surgical manpower requirements and vascular surgical rates in the United States. J Vasc Surg 1986, 3:74-83.
2. Martin E.C. Transcatheter therapies in peripheral and noncoronary vascular disease: introduction. Circulation 1991, 83:I1-I5.
3. Waugh J.R., Sacharias N. Arteriographic complications in the DSA era. Radiology 1992, 182:243-246.
4. Malden E.S., Picus D., Vesely T.M., Darcy M.D., Hicks M.E. Peripheral vascular disease: evaluation with stepping DSA and conventional screen-film angiography. Radiology 1994, 191:149-153.
5. Picus D., Hicks M.E., Darcy M.D., Kleinhoffer M.A. Comparison of nonsubtracted digital angiography and conventional screen-film angiography for the evaluation of patients with peripheral vascular disease. J Vasc Interv Radiol 1991, 2:359-364.
6. Kaufman J., Michael L. Vascular and interventional radiology: the requisites 2004, Mosby, Philadelphia.
7. Levy E., Viscoli C.M., Horwitz R.I. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996, 275:1489-1494.
8. Pannu N., Wiebe N., Tonelli M., et al. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006, 295:2765-2779.
9. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. JAMA 2004, 291:2328-2334.
10. Marenzi G., Assanelli E., Marana I., et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006, 354(26):2773-2782.
11. Liu R., Nair D., Ix J., Moore D.H., Bent S. N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. J Gen Intern Med 2005, 20(2):193-200.
12. Birck R., Krzossok S., Markowetz F., Schnulle P., van der Woude F.J., Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003, 362(9384):598-603.
13. Hawkins I.F. Carbon dioxide digital subtraction arteriography. AJR Am J Roentgenol 1982, 139(1):19-24.
14. Wilson A.J., Boxer M.M. Neurotoxicity of angiographic carbon dioxide in the cerebral vasculature. Invest Radiol 2002, 37(10):542-551.
15. Deleted in proof.
16. Deleted in proof.
17. Wedeen V.J., Meuli R.A., Edelman R.R., et al. Projective imaging of pulsatile flow with magnetic resonance. Science 1985, 230(4728):946-948.
18. Ho K.Y., Leiner T., de Haan M.W., et al. Peripheral MR angiography. Eur Radiol 1999, 9:1765-1774.
19. Mustert B.R., Williams D.M., Prince M.R. In vitro model of arterial stenosis: correlation of MR signals dephasing and trans-stenotic pressure gradients. Magn Reson Imaging 1998, 16:301-310.
20. Miyazaki M., Takai H., Sugiura S., et al. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology 2003, 227:890-896.
21. Miyazaki M., Sugiura S., Tateishi F., et al. Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo. J Magn Reson Imaging 2000, 12:776-783.
22. Foo T.K., Ho V.B., Marcos H.B., et al. MR angiography using steady-state free precession. Magn Reson Med 2002, 48:699-706.
23. Nael K., Fenchel M.C., Kramer U., Finn J.P., Ruehm S.G. Whole-body contrast-enhanced magnetic resonance angiography: new advances at 3.0 T. Top Magn Reson Imaging 2007, 18(2):127-134.
24. Swaminathan S., Horn T.D., Pellowski D., et al. Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. N Engl J Med 2007, 357(7):720-722.
25. Schmiedl U., Moseley M.E., Ogan M.D., et al. Comparison of initial biodistribution patterns of Gd-DTPA and albumin-(Gd-DTPA) using rapid spin echo MR imaging. J Comput Assist Tomogr 1987, 11:306-313.
26. Prince M.R., Grist T.M., Debatin J.F. 3D Contrast MR angiography 2003, Springer, Berlin.
27. Boos M., Scheffler K., Haselhorst R., et al. Arterial first pass gadolinium-CM dynamics as a function of several intravenous saline flush and Gd volumes. J Magn Reson Imaging 2001, 13:568-576.
28. Yip Y.P., Capriotti C., Talagala S.L., Yip J.W. Effects of MR exposure at 1.5 on early embryonic development of the chick. J Magn Reson Imaging 1994, 4:742-748.
29. U.S. Food and Drug Administration. Public health advisory: gadolinium-containing contrast agents for magnetic resonance imaging (MRI)-Omniscan, OptiMARK, Magnevist, ProHance, and MultiHance. Available at: . Accessed November 19, 2007. http://www.fda.gov.
30. Thomsen H.S. European Society of Urogenital Radiology (ESUR). ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 2007, 17:2692-2696.
31. Levey A.S., Coresh J., Balk E., et al. National kidney practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med 2003, 139:137-147.
32. Wertman B., Altun E., Martin D., et al. Risk of Nephrogenic Systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities. Radiology 2008, 248(3):799-806.
33. Okada S., Katagiri K., Kumazaki T., Yokoyama H. Safety of gadolinium contrast agent in hemodialysis patients. Acta Radiologica 2001, 42:339.
34. Korosec F.R., Frayne R., Grist T.M., Mistretta C.A. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996, 36(3):345-351.
35. Hany T.F., Debatin J.F., Leung D.A., et al. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997, 204:357-362.
36. Prince M.R. Contrast-enhanced MR angiography: theory and optimization. Magn Reson Imaging Clin N Am 1998, 6:257-267.
37. Ho K.Y., Leiner T., van Engelshoven J.M. MR angiography of run-off vessels. Eur Radiol 1999, 9:1285-1289.
38. Vasbinder G.B., Nelemans P.J., Kessels A.G., et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004, 141:674-682.
39. Schoenberg S.O., Rieger J., Weber C.H., et al. High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and U.S. Radiology 2005, 235:687-698.
40. Huang Y., Webster C.A., Wright G.A. Analysis of subtraction methods in three-dimensional contrast-enhanced peripheral MR angiography. J Magn Reson Imaging 2002, 15:541-550.
41. Ruehm S.G., Nanz D., Baumann A., et al. 3D contrast-enhanced MR angiography of the run-off vessels: value of image subtraction. J Magn Reson Imaging 2001, 13:402-411.
42. Rofsky N.M., Morana G., Adelman M.A., et al. Improved gadolinium-enhanced subtraction MR angiography of the femoropopliteal arteries: reintroduction of osseous anatomic landmarks. AJR Am J Roentgenol 1999, 173:1009-1011.
43. Westenberg J.J., Wasser M.N., van der Geest R.J., et al. Scan optimization of gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries with multiple bolus injections and in vitro validation of stenosis quantification. Magn Reson Imaging 1999, 17:47-57.
44. Hany T.F., Schmidt M., Davis C.P., et al. Diagnostic impact of four postprocessing techniques in evaluating contrast-enhanced three-dimensional MR angiography. AJR Am J Roentgenol 1998, 170:907-912.
45. Nelemans P.J., Leiner T., de Vet H.C., et al. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 2000, 217:105-114.
46. Westenberg J.J., van der Geest R.J., Wasser M.N., et al. Vessel diameter measurements in gadolinium contrast-enhanced three-dimensional MRA of peripheral arteries. Magn Reson Imaging 2000, 18:13-22.
47. Ouwendijk R., de Vries M., Stijnen T., et al. Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: The DIPAD trial. AJR Am J Roentgenol 2008, 190:1349-1357.
48. Ouwendijk R., de Vries M., Pattynama P., et al. Imaging peripheral arterial disease: a randomized controlled trial comparing contrast-enhanced MR angiography and multi-detector row CT angiography. Radiology 2005, 236:1094-1103.
49. Adriaensen M.E., Kock M.C., Stijnen T., et al. Peripheral arterial disease: therapeutic confidence of CT versus digital subtraction angiography and effects on additional imaging recommendations. Radiology 2004, 233:385-391.
50. Deleted in proof.
51. Deleted in proof.
52. Deleted in proof.
53. Martin M.L., Tay K.H., Flak B., et al. Multidetector CT angiography of the aortoiliac system and lower extremities: a prospective comparison with digital subtraction angiography. AJR Am J Roentgenol 2003, 180:1085-1091.
54. Portugaller H.R., Schoellnast H., Hausegger K.A., Tiesenhausen K., Amann W., Berghold A. Multi-slice spiral CT angiography in peripheral arterial occlusive disease: a valuable tool in detecting significant arterial lumen narrowing?. Eur Radiol 2004, 14:1681-1687.
55. Ofer A., Nitecki S.S., Linn S., et al. Multidetector CT angiography of peripheral vascular disease: a prospective comparison with intra-arterial digital subtraction angiography. AJR Am J Roentgenol 2003, 180:719-724.
56. Romano M., Mainenti P.P., Imbriaco M. Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement. Eur J Radiol 2004, 50:303-308.
57. Hertzer N.R. The natural history of peripheral vascular disease: implications for its management. Circulation 1991, 83:I12-I19.
58. Brewster D.C. Direct reconstruction for aortoiliac occlusive disease. Vascular surgery 2000, 943-972. WB Saunders, Philadelphia. R.B. Rutherford (Ed.).
59. Loewe C., Schoder M., Rand T., et al. Peripheral vascular occlusive disease: evaluation with contrast-enhanced moving-bed MR angiography versus digital subtraction angiography in 106 patients. AJR Am J Roentgenol 2002, 179:1013-1021.
60. Hentsch A., Aschauer M.A., Balzer J.O. Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography. Eur Radiol 2003, 13:2103-2114.
61. Binkert C.A., Baker P.D., Petersen B.D., Szumowski J., Kaufman J.A. Peripheral vascular disease: blinded study of dedicated calf MR angiography versus standard bolus-chase MR angiography and film hard-copy angiography. Radiology 2004, 232(3):860-866.
62. Janka R., Fellner C., Wenkel E., Lang W., Bautz W., Fellner F.A. Contrast-enhanced MR angiography of peripheral arteries including pedal vessels at 1.0 T: feasibility study with dedicated peripheral angiography coil. Radiology 2005, 235(1):319-326.
63. Meissner O.A., Rieger J., Weber C., et al. Critical limb ischemia: hybrid MR angiography compared with DSA. Radiology 2005, 235(1):308-318.
64. Menzoian J.O., LaMorte W.W., Paniszyn C.C., et al. Symptomatology and anatomic patterns of peripheral vascular disease: differing impact of smoking and diabetes. Ann Vasc Surg 1989, 3:224-228.
65. Cigarroa J.E., Isselbacher E.M., DeSanctis R.W., Eagle K.A. Diagnostic imaging in the evaluation of suspected aortic dissection: old standards and new directions. N Engl J Med 1993, 328:35-43.
66. Nienaber C.A., Fattori R., Lund G., et al. Nonsurgical reconstruction of thoracic aortic dissection by stent graft placement. N Engl J Med 1999, 340:1539-1545.
67. Ballal R.S., Nanda N.C., Gatewood R., et al. Usefulness of transesophageal echocardiography in assessment of aortic dissection. Circulation 1991, 84(5):1903-1914.
68. Laissy J.P., Blanc F., Soyer P., et al. Thoracic aortic dissection: diagnosis with transesophageal echocardiography versus MR imaging. Radiology 1995, 194(2):331-336.
69. Nienaber C.A., von Kodolitsch Y., Nicolas V., et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med 1993, 328(1):1-9.
70. Sommer T., Fehske W., Holzknecht N., et al. Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology 1996, 199(2):347-352.
71. Yoshida S., Akiba H., Tamakawa M., et al. Thoracic involvement of type A aortic dissection and intramural hematoma: diagnostic accuracy-comparison of emergency helical CT and surgical findings. Radiology 2003, 228(2):430-435.
72. Nevitt M.P., Ballard D.J., Hallett J.W. Prognosis of abdominal aortic aneurysms: a population-based study. N Engl J Med 1989, 321:1009-1014.
73. Ernst C.B. Abdominal aortic aneurysm. N Engl J Med 1993, 328:1167-1172.
74. Reed W.W., Hallett J.W., Damiano M.A., et al. Learning from the last ultrasound: a population-based study of patients with abdominal aortic aneurysm. Arch Intern Med 1997, 157:2064-2068.
75. Brewster D.C., Cronenwett J.L., Hallett J.W., et al. Guidelines for the treatment of abdominal aortic aneurysms: report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 2003, 37:1106-1117.
76. Isselbacher E.M. Thoracic and abdominal aortic aneurysms. Circulation 2005, 111:816-828.
77. Moore W.S., Rutherford R.B. Transfemoral endovascular repair of abdominal aortic aneurysm: results of the North American EVT phase 1 trial-EVT investigators. J Vasc Surg 1996, 23:543-553.
78. Baum R.A., Stavropoulos S.W., Fairman R.M., et al. Endoleaks after endovascular repair of abdominal aortic aneurysms. J Vasc Interv Radiol 2003, 14:1111-1117.
79. McGuigan E.A., Sears S.T., Corse W.R., et al. MR angiography of the abdominal aorta. Magn Reson Imaging Clin N Am 2005, 13:65-89.
80. Dent T.L., Lindenauer S.M., Ernst C.B., et al. Multiple arteriosclerotic arterial aneurysms. Arch Surg 1972, 105:338-344.
81. Wright L.B., Matchett W.J., Cruz C.P., et al. Popliteal artery disease: diagnosis and treatment. Radiographics 2004, 24:467-479.
82. Goodman L.R., Lipchik R.J., Kuzo R.S., et al. Subsequent pulmonary embolism: risk after a negative helical CT pulmonary angiogram-prospective comparison with scintigraphy. Radiology 2000, 215:535-542.
83. Schoepf U. Pulmonary artery CTA. Tech Vasc Interv Radiol 2006, 9(4):180-191.
84. Haage P., Piroth W., Krombach G., et al. Pulmonary embolism: comparison of angiography with spiral CT, MRA and real-time MR imaging. Am J Respir Crit Care Med 2003, 167(5):729-734.
85. Kluge A., Mueller C., Strunk J., et al. Experience in 207 combined MRI examinations for acute pulmonary embolism and deep vein thrombosis. AJR Am J Roentgenol 2006, 186:1686-1696.
86. Kluge A., Rominger M., Schönburg M., Bachmann G. Indirect MR venography: contrast media protocols, postprocessing and combination with MRI diagnostics for pulmonary embolism. Rofo 2004, 176:976-984.
87. Oudkerk M., van Beek E.J., Wielopolski P., et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002, 359:1643-1647.
88. Willinsky R.A., Taylor S.M., TerBrugge K., et al. Neurologic complications of cerebral angiography: prospective analysis of 2899 procedures and review of the literature. Radiology 2003, 227:522-528.
89. Long A., Lepoutre A., Corbillon E., Branchereau A. Critical review of non- or minimally invasive methods: duplex ultrasonography, MR, and CT angiography. Eur J Vasc Endovasc Surg 2002, 24:43-52.
90. Silvennoinen H.M., Ikonen S., Soinne L., et al. CT angiographic analysis of carotid artery stenosis: comparison of manual assessment, semiautomatic vessel analysis, and digital subtraction angiography. AJNR Am J Neuroradiol 2007, 28:97-103.
91. de Wert T.T., Outhouse M., Mitering E., et al. In vivo characterization and quantification of atherosclerotic carotid plaque components with MDCT and histopathological correlation. Arterioscler Thromb Vascul Biol 2006, 26:2366-2372.
92. Wintermark M., Fischbein N.J., Smith W.S., et al. Accuracy of dynamic perfusion CT with deconvolution in detecting acute hemispheric stroke. AJNR Am J Neuroradiol 2005, 26:104-112.
93. Grant E.G., Benson C.B., Moneta G.L., et al. Carotid artery stenosis: gray-scale and Doppler U.S. diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003, 229:340-346.
94. Landwehr P., Schulte O., Voshage G. Ultrasound examination of carotid and vertebral arteries. Eur Radiol 2001, 11:1521-1534.
95. van Everdingen K.J., van der Grond J., Kappelle L.J. Overestimation of a stenosis in the internal carotid artery by duplex sonography caused by an increase in volume flow. J Vasc Surg 1998, 27:479-485.
96. Ota H., Takase K., Rikimaru H., et al. Quantitative vascular measurements in arterial occlusive disease. Radiographics 2005, 25(5):1141-1158.
97. Ouhlous M., Flach H.Z., de Weert T.T., et al. Carotid plaque composition and cerebral infarction: MR imaging study. AJNR Am J Neuroradiol 2005, 26(5):1044-1049.
98. Raggi P., Taylor A., Fayad Z., et al. Atherosclerotic plaque imaging: contemporary role in preventive cardiology. Arch Intern Med 2005, 165(20):2345-2353.
99. Kampschulte A., Ferguson M.S., Kerwin W.S., et al. Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 2004, 110(20):3239-3244.
100. Hatsukami T.S., Ross R., Polissar N.L., Yuan C. Carotid plaque in vivo with high-resolution magnetic resonance imaging visualization of fibrous cap thickness and rupture in human atherosclerotic. Circulation 2000, 102:959-964.
101. Laugharne M., Haslam E., Archer L., et al. Multidetector CT angiography in live donor renal transplantation: experience from 156 consecutive cases at a single centre. Transpl Int 2007, 20:156-166.
102. Deleted in proof.
103. Rountas C., Vlychou M., Vassiou K., et al. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler U.S., CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren Fail 2007, 29:295-302.
104. Schlunt L.B., Harper J.D., Broome D.R., et al. Improved detection of renal vascular anatomy using multidetector CT angiography: is 100% detection possible?. J Endourol 2007, 21:12-17.
105. Raman S.S., Pojchamarnwiputh S., Muangsomboon K., et al. Utility of 16-MDCT angiography for comprehensive preoperative vascular evaluation of laparoscopic renal donors. AJR Am J Roentgenol 2006, 186:1630-1638.
106. Kim T., Murakami T., Takahashi S., et al. Evaluation of renal arteries in living renal donors: comparison between MDCT angiography and gadolinium-enhanced 3D MR angiography. Radiat Med 2006, 24:617-624.
107. Deleted in proof.
108. Derkx F.H., Schalekamp M.A. Renal artery stenosis and hypertension. Lancet 1994, 344:237-239.
109. Working Group on Renovascular Hypertension. Detection, evaluation, and treatment of renovascular hypertension: final report. Arch Intern Med 1987, 147:820-829.
110. Fain S.B., King B.F., Breen J.F., et al. High-spatial-resolution contrast-enhanced MR angiography of the renal arteries: a prospective comparison with digital subtraction angiography. Radiology 2001, 218:481-490.
111. Shetty A.N., Bis K.G., Kirsch M., et al. Contrast-enhanced breath-hold three-dimensional magnetic resonance angiography in the evaluation of renal arteries: optimization of technique and pitfalls. J Magn Reson Imaging 2000, 12:912-923.
112. Bude R.O., Forauer A.R., Caoili E.M., et al. Is it necessary to study accessory arteries when screening the renal arteries for renovascular hypertension?. Radiology 2003, 226:411-416.
113. Vasbinder G.B., Nelemans P.J., Kessels A.G., et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001, 135:401-411.
114. Hoogeveen R.M., Bakker C.J., Viergever M.A. Limits to the accuracy of vessel diameter measurement in MR angiography. J Magn Reson Imaging 1998, 8:1228-1235.
115. Safian R.D., Textor S.C. Renal-artery stenosis. N Engl J Med 2001, 344:431-442.
116. Schoenberg S.O., Prince M.R., Knopp M.V., et al. Renal MR angiography. Magn Reson Imaging Clin N Am 1998, 6:351-370.
117. Vasbinder G.B., Maki J.H., Nijenhuis R.J., et al. Motion of the distal renal artery during three-dimensional contrast-enhanced breath-hold MRA. J Magn Reson Imaging 2002, 16:685-696.
118. Bakker J., Beek F.J., Beutler J.J., et al. Renal artery stenosis and accessory renal arteries: accuracy of detection and visualization with gadolinium-enhanced breath-hold MR angiography. Radiology 1998, 207:497-504.
119. Huda W. Radiation dosimetry in diagnostic radiology. AJR Am J Roentgenol 1997, 169:1487-1488.
120. Hall E.J., Giaccia A.J. Radiobiology for the radiologist 2006, Lippincott Williams & Wilkins, Philadelphia. 6th ed.
121. Wagner L.K., Eifel P.J., Geise R.A. Potential biological effects following high x-ray dose interventional procedures. J Vasc Inter Radiol 1994, 5:71-84.
122. Gkanatsios N.A., Huda W., Peters K.R. Adult patient doses in interventional neuroradiology. Med Phys 2002, 29:717-723.
123. U.S. Food and Drug Administration. Avoidance of serious x-ray induced skin injuries to patients during fluoroscopically-guided procedures (1994). Available at: . Accessed March 30, 2009. http://www.fda.gov.
124. International Commission on Radiological Protection. 2008 recommendations of the International Commission on Radiological Protection. Publication 103. Annals of the IRCP 2007;37:204.
125. National Academy of Sciences Committee on the Biological Effects of Ionizing Radiation. Health effects of exposure to low levels of ionizing radiations: time for reassessment? Report VII. Washington, DC: BEIR; 2005.
126. United Nations Scientific Committee on the Effects of Atomic Radiation Sources and effects of ionizing radiation 2000, UNSEAR, New York.
127. National Council on Radiation Protection and Measurements. Exposure of the U.S. population from diagnostic medical radiation. Report 100. Washington, DC: NCRP; 1989.